A family with 2 siblings with severe spinal muscular atrophy with respiratory distress 1 (SMARD1) was genetically proved to be caused by mutations in IGHMBP2 gene. Both patients developed progressive muscular weakness and respiratory distress and died before 6 months of age. One novel deletion, c.780delG;p.(Gln260Hisfs*24), inherited from the father and a nonsense mutation, c.1488C>A;p.(Cys496*), inherited from the mother were detected. An attempt was made to correlate the genetic-clinical data available in the literature. The clinical case presented in this study might be considered as the most severe form of spinal muscular atrophy respiratory distress 1 reported so far, presumably because of the total absence of IGHMBP2 enzyme activity.
GrohmannKSchuelkeMDiersA. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet. 2001;29:75–77.
2.
EckartMGuentherUPIdkowiakJ. The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Pediatrics. 2012;129:e148–e156.
3.
PittMHouldenHJacobsJ. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain. 2003;126:2682–2692.
4.
GrohmannKVaronRStolzP. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol. 2003;54:719–724.
5.
GuentherUPVaronRSchlickeM. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat. 2007;28:808–815.
6.
KaindlAMGuentherUPRudnik-SchönebornS. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). J Child Neurol. 2008;23:199–204.
7.
GuentherUPSchuelkeMBertiniE. Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1. Hum Genet. 2004;115:319–326.
8.
KaindlAMGuentherUPRudnik-SchönebornS. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). J Child Neurol. 2008;23:199–204.
9.
GrohmannKVaronRStolzP. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol. 2003;54:719–724.
10.
Rudnik-SchonebornSForkertRHahnenE. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropediatrics. 1996;27:8–15.
11.
GrohmannKWienkerTFSaarK. Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21 [letter]. Am J Hum Genet. 1999;65:1459–1462.
12.
MellinsRBHaysAPGoldAP. Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease. Pediatrics. 1974;53:33–40.
13.
GuentherUPVaronRSchlickeM. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat. 2007;28:808–815.
14.
GrohmannKSchuelkeMDiersA. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet. 2001;29:75–77.
15.
TachiNKikuchiSKozukaNNogamiA. A new mutation of IGHMBP2 gene in spinal muscular atrophy with respiratory distress type 1. Pediatr Neurol. 2005;32:288–290.
16.
GuentherUPSchuelkeMGrohmannK. A new mutation of IGHMBP2 gene. Pediatr Neurol. 2006;34:168.
17.
MaystadtIZarhrateMLandrieuP. Allelic heterogeneity of SMARD1 at the IGHMBP2 locus. Hum Mutat. 2004;23:525–526.
18.
GuentherUPHandokoLLaggerbauerB. IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Hum Mol Genet. 2009;18:1288–1300.
19.
de Planell-SaguerMSchroederDGRodicioMC. Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet. 2009;18:2115–21126.
